1) Shumaker SA, Legault C, Rapp SR, et al : Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women : a randomized controlled trial. The Women's Health Initiative Memory Study. JAMA 289 : 2651─2662, 2003
2) Shumaker SA, Legault C, Kuller L, et al : Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women : Women's Health Initiative Memory Study. JAMA 291 : 2947─2958, 2004
3) Maki PM : A systemic review of clinical trials of hormone therapy on cognitive function : effects of age at initiation and progestin use. Ann NY Acad Sci 1052 : 182─197, 2005
4) Maki PM, Sundermann E : Hormone therapy and cognitive function. Hum Reprod Update 15 : 667─681, 2009
5) Hogervorst E, Bandelow S : Sex steroids to maintain cognitive function in women after the menopause : a meta-analysis of treatment trials. Maturitas 66 : 56─71, 2010
6) Brown TJ, Scherz B, Hochberg RB, et al : Regulation of estrogen receptor concentrations in the rat brain : effects of sustained androgen and estrogen exposure. Neuroendocrinology 63 : 53─60, 1996
7) Ohkura T, Isse K, Akazawa K, et al : Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause 1 : 125─130, 1994
8) Ohkura T, Isse K, Akazawa K, et al : Low-term estrogen replacement therapy in female patients with dementia of the Alzheimer type : 7 case reports. Dementia 6 : 99─107, 1995
9) 大藏健義 : 女性ホルモンと認知機能.女性心身医学16 : 264─267, 2012
10) Hogervorst E, Williams J, Budge M, et al : The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women : a meta-analysis. Neuroscience 101 : 485─512, 2000
11) LeBlanc ES, Janowsky J, Chan BK, et al : Hormone replacement therapy and cognition : systematic review and meta-analysis. JAMA 285 : 1489─1499, 2001
12) Seshadri S, Zornberg GL, Derby LE, et al : Risk of Alzheimer disease is not reduced by estrogen replacement therapy. Arch Neurol 58 : 435─440, 2001
13) Zandi PP, Carlson MC, Plassman BL, et al : Hormone replacement therapy and incidence of Alzheimer's disease in older women. The Cache Country Study. JAMA 288 : 2123─2129, 2002
14) Henderson VW, Benke KS, Green RC, et al : Postmenopausal hormone therapy and Alzheimer's disease risk : interaction with age. J Neurosurg Psychiatry 76 : 103─105, 2005
15) Tang MX, Jacobs D, Stern Y, et al : Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 : 429─432, 1996
16) Maki PM : Effects of hormone therapy on cognitive function : state of the science post-WHI. Menopause Management 14 : 10─21, 2005
17) Whitmer RA, Quesenberry CP, Zhou J, et al : Timing of hormone therapy and dementia : the critical window theory revisited. Ann Neurol 69 : 163─169, 2011
18) Studd J, Panay N : Hormone and depression in women. Climacteric 7 : 338─346, 2004(レベルIV)
19) 川上憲人 : うつ病の疫学と国際比較.日本臨床65 : 1578─1584,2007(レベルIV)
20) Bungay GT, Vessey MP, McPherson CK : Study of symptoms in middle life with special reference to the menopause. Br Med J 281 : 181─183, 1980(レベルIII)
21) Stewart DE, Boydell K, Derzko C, et al : Psychologic distress during the menopausal years in women attending a menopause clinic. Int J Psychiatry Med 22 : 213─220, 1992(レベルIII)
22) Hay AG, Bancroft J, Johnstone EC : Affective symptoms in women attending a menopause clinic. Br J Psychiatry 164 : 513─516, 1994(レベルIII)
23) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 4 th edn revised. American Psychiatric Association, Washington DC, 1994
24) Zweifel JE, O'Brien WH : A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoendocrinology 22 : 189─212, 1997(レベルI)
25) Montgomery JC, Appleby L, Brincat M, et al : Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 329 : 297─299, 1987(レベルII)
26) Ditkoff EC, Crary WG, Cristo M, et al : Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78 : 991─995, 1991(レベルII)
27) Best NR, Rees MP, Barlow DH, et al : Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17 : 87─93, 1992(レベルIII)
28) Palinkas LA, Barrett-Conner E : Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 80 : 30─36, 1992(レベルIII)
29) Daly E, Gray A, Barlow D, et al : Measuring the impact of menopausal symptoms on quality of life. Br Med J 307 : 836─840, 1993(レベルIII)
30) Limouzin-Lamothe MA, Mairon N, Joyce CR, et al : Quality of life after the menopause : influence of hormonal replacement therapy. Am J Obstet Gynecol 170 : 618─624, 1994(レベルII)
31) Schmidt PJ, Nieman L, Danaceau MA, et al : Estrogen replacement in perimenopause-related depression : a preliminary report. Am J Obstet Gynecol 183 : 414─420, 2000(レベルII)
32) Soares CN, Almeida OP, Joffe H, et al : Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 58 : 529─534, 2001(レベルII)
33) Morrison MF, Kallan MJ, Ten Have T, et al : Lack of efficacy of estradiol for depression in postmenopausal women : a randomized, controlled trial. Biol Psychiatry 55 : 406─412, 2004(レベルII)
34) Rudolph I, Palombo-Kinne E, Kirsch B, et al : Influence of a continuous combined HRT(2mg estradiol valerate and 2 mg dienogest)on postmenopausal depression. Climacteric 7 : 301─311, 2004(レベルII)
35) Carranza-Lira S, Valentino-Fiqueroa ML : Estrogen therapy for depression in postmenopausal women. Int J Gynecol Obstet 65 : 35─38, 1999(レベルIII)
36) Rasgon NL, Altshuler LL : Estrogen-replacement therapy for depression. Am J Psychiatry 158 : 1738, 2001(レベルIV)
37) Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL : Short-term use of estradiol for depression in perimenopausal and postmenopausal women : a preliminary report. Am J Psychiatry 160 : 1519─1522, 2003(レベルIII)
38) 大藏健義,濱田佳伸,矢追正幸,友部勝実,安藤昌守,林 雅敏 : 閉経後女性のうつ病と更年期障害に対するエストロゲン補充療法(ERT),選択的セロトニン再取り込み阻害薬(SSRI)療法およびERT+SSRI併用療法の治療効果に関する臨床的研究.日更年医誌 12 : 34─41,2004(レベルIII)